A61K 38/29
Parathyroid hormone, i.e. parathormone
Official title: Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
A61K38/29 (Parathyroid hormone, i.e. parathormone) appears on 396 US grants and 690 published applications in this corpus.
Search patents in A61K- Granted patents
- 396
- Published applications
- 690
- Assignees
- 264
- Inventors
- 925
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 6 | 0 |
| 1997 | 8 | 0 |
| 1998 | 12 | 0 |
| 1999 | 12 | 0 |
| 2000 | 8 | 0 |
| 2001 | 4 | 3 |
| 2002 | 8 | 17 |
| 2003 | 8 | 25 |
| 2004 | 5 | 19 |
| 2005 | 11 | 40 |
| 2006 | 11 | 29 |
| 2007 | 7 | 37 |
| 2008 | 12 | 35 |
| 2009 | 12 | 28 |
| 2010 | 18 | 30 |
| 2011 | 10 | 29 |
| 2012 | 18 | 17 |
| 2013 | 18 | 25 |
| 2014 | 29 | 31 |
| 2015 | 15 | 26 |
| 2016 | 25 | 21 |
| 2017 | 16 | 26 |
| 2018 | 15 | 26 |
| 2019 | 15 | 31 |
| 2020 | 11 | 32 |
| 2021 | 17 | 25 |
| 2022 | 13 | 28 |
| 2023 | 15 | 37 |
| 2024 | 12 | 28 |
| 2025 | 16 | 27 |
| 2026 | 1 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polypeptide formulations for oral delivery27 Jan 2026US 12,533,321 B2Bhami's Research Laboratory, Pvt. Ltd.
- Methods of improving spinal fusion with abaloparatide16 Dec 2025US 12,496,330 B2Radius Health, Inc.
- Incremental dose finding in controlled-release PTH compounds28 Oct 2025US 12,453,778 B2Ascendis Pharma Bone Diseases A/S
- Liquid polymer delivery system for extended administration of drugs21 Oct 2025US 12,447,158 B2Tolmar International Limited
- Liquid pharmaceutical formulations of PTH conjugates2 Sep 2025US 12,403,182 B2Ascendis Pharma Bone Diseases A/S
- Cells expressing parathyroid hormone 1 receptor and uses thereof24 Sep 2026US 2026/0286293 A1Tithon Biotech Inc.
- Treatment and prevention of osteoporosis in high body mass index individuals17 Sep 2026US 2026/0273025 A1Radius Health, Inc.
- Peptide pharmaceuticals for insulin resistance17 Sep 2026US 2026/0273069 A1Mederis Diabetes LLC
- Cells expressing parathyroid hormone 1 receptor and uses thereof17 Sep 2026US 2026/0275277 A1Tithon Biotech Inc.
- Polypeptide pharmaceuticals27 Aug 2026US 2026/0248925 A1Mederis Diabetes LLC
Most cited
By later US patents
- Spray drying of macromolecules to produce inhaleable dry powders220US 6,582,728 B1Inhale Therapeutic Systems · 2003
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Swallowable drug delivery device and methods of drug delivery154US 8,721,620 B2Rani Therapeutics, LLC · 2014
- Device, system and methods for the oral delivery of therapeutic compounds138US 8,734,429 B2Rani Therapeutics, LLC · 2014
- Gene transfer into bone cells and tissues132US 5,763,416 AThe Regent of the University of Michigan · 1998